Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fox Chase Cancer Center
With
Sirtex Medical
Patients with adequate liver function and performance status in whom liver-directed therapy and capecitabine would be appropriate are eligible for this clinical trial.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adequate liver function
Adequate performance status
You may not be if
Significant extrahepatic disease
Clareo Health | Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
